AR and neoplasm: We have previously studied tumor cell AR activity in prostate cancer bone metastases [7,22] and mechanisms driving AR activity in CRPC, such as intra-tumoral steroidogenesis and expression of constitutively active AR variant 7 (AR-V7) [5,6].